{
    "title": "Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.",
    "abst": "1. The catalepsy induced by dopamine antagonists has been tested and the possible dopamine subtypes involved in catalepsy was determined. 2. Dopamine antagonist fluphenazine, D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced catalepsy. The effect of fluphenazine and sulpiride was dose-dependent. Combination of SCH 23390 with sulpiride did not induce catalepsy potentiation. 3. D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the catalepsy induced by fluphenazine, SCH 23390 or sulpiride. 4. Combination of SKF 38393 with quinpirole did not cause potentiated inhibitory effect on catalepsy induced by dopamine antagonists. 5. The data may indicate that although D-2 receptor blockade is involved in catalepsy, the D-1 receptor may plan a role.",
    "title_plus_abst": "Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice. 1. The catalepsy induced by dopamine antagonists has been tested and the possible dopamine subtypes involved in catalepsy was determined. 2. Dopamine antagonist fluphenazine, D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced catalepsy. The effect of fluphenazine and sulpiride was dose-dependent. Combination of SCH 23390 with sulpiride did not induce catalepsy potentiation. 3. D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the catalepsy induced by fluphenazine, SCH 23390 or sulpiride. 4. Combination of SKF 38393 with quinpirole did not cause potentiated inhibitory effect on catalepsy induced by dopamine antagonists. 5. The data may indicate that although D-2 receptor blockade is involved in catalepsy, the D-1 receptor may plan a role.",
    "pubmed_id": "1687392",
    "entities": [
        [
            29,
            37,
            "dopamine",
            "Chemical",
            "D004298"
        ],
        [
            59,
            68,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            85,
            94,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            106,
            114,
            "dopamine",
            "Chemical",
            "D004298"
        ],
        [
            160,
            168,
            "dopamine",
            "Chemical",
            "D004298"
        ],
        [
            190,
            199,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            219,
            227,
            "Dopamine",
            "Chemical",
            "D004298"
        ],
        [
            239,
            251,
            "fluphenazine",
            "Chemical",
            "D005476"
        ],
        [
            268,
            277,
            "SCH 23390",
            "Chemical",
            "C534628"
        ],
        [
            296,
            305,
            "sulpiride",
            "Chemical",
            "D013469"
        ],
        [
            314,
            323,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            339,
            351,
            "fluphenazine",
            "Chemical",
            "D005476"
        ],
        [
            356,
            365,
            "sulpiride",
            "Chemical",
            "D013469"
        ],
        [
            401,
            410,
            "SCH 23390",
            "Chemical",
            "C534628"
        ],
        [
            416,
            425,
            "sulpiride",
            "Chemical",
            "D013469"
        ],
        [
            441,
            450,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            480,
            489,
            "SKF 38393",
            "Chemical",
            "D015647"
        ],
        [
            505,
            515,
            "quinpirole",
            "Chemical",
            "D019257"
        ],
        [
            530,
            539,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            551,
            563,
            "fluphenazine",
            "Chemical",
            "D005476"
        ],
        [
            565,
            574,
            "SCH 23390",
            "Chemical",
            "C534628"
        ],
        [
            578,
            587,
            "sulpiride",
            "Chemical",
            "D013469"
        ],
        [
            607,
            616,
            "SKF 38393",
            "Chemical",
            "D015647"
        ],
        [
            622,
            632,
            "quinpirole",
            "Chemical",
            "D019257"
        ],
        [
            680,
            689,
            "catalepsy",
            "Disease",
            "D002375"
        ],
        [
            701,
            709,
            "dopamine",
            "Chemical",
            "D004298"
        ],
        [
            799,
            808,
            "catalepsy",
            "Disease",
            "D002375"
        ]
    ],
    "split_sentence": [
        "Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.",
        "1.",
        "The catalepsy induced by dopamine antagonists has been tested and the possible dopamine subtypes involved in catalepsy was determined.",
        "2.",
        "Dopamine antagonist fluphenazine, D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced catalepsy.",
        "The effect of fluphenazine and sulpiride was dose-dependent.",
        "Combination of SCH 23390 with sulpiride did not induce catalepsy potentiation.",
        "3.",
        "D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the catalepsy induced by fluphenazine, SCH 23390 or sulpiride.",
        "4.",
        "Combination of SKF 38393 with quinpirole did not cause potentiated inhibitory effect on catalepsy induced by dopamine antagonists.",
        "5.",
        "The data may indicate that although D-2 receptor blockade is involved in catalepsy, the D-1 receptor may plan a role."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "D004298\tChemical\tdopamine\tBlockade of both D-1 and D-2 <target> dopamine </target> receptors may induce catalepsy in mice .",
        "D002375\tDisease\tcatalepsy\tBlockade of both D-1 and D-2 dopamine receptors may induce <target> catalepsy </target> in mice .",
        "D002375\tDisease\tcatalepsy\tThe <target> catalepsy </target> induced by dopamine antagonists has been tested and the possible dopamine subtypes involved in catalepsy was determined .",
        "D004298\tChemical\tdopamine\tThe catalepsy induced by <target> dopamine </target> antagonists has been tested and the possible dopamine subtypes involved in catalepsy was determined .",
        "D004298\tChemical\tdopamine\tThe catalepsy induced by dopamine antagonists has been tested and the possible <target> dopamine </target> subtypes involved in catalepsy was determined .",
        "D002375\tDisease\tcatalepsy\tThe catalepsy induced by dopamine antagonists has been tested and the possible dopamine subtypes involved in <target> catalepsy </target> was determined .",
        "D004298\tChemical\tDopamine\t<target> Dopamine </target> antagonist fluphenazine , D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced catalepsy .",
        "D005476\tChemical\tfluphenazine\tDopamine antagonist <target> fluphenazine </target> , D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced catalepsy .",
        "C534628\tChemical\tSCH 23390\tDopamine antagonist fluphenazine , D-1 antagonist <target> SCH 23390 </target> or D-2 antagonist sulpiride induced catalepsy .",
        "D013469\tChemical\tsulpiride\tDopamine antagonist fluphenazine , D-1 antagonist SCH 23390 or D-2 antagonist <target> sulpiride </target> induced catalepsy .",
        "D002375\tDisease\tcatalepsy\tDopamine antagonist fluphenazine , D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced <target> catalepsy </target> .",
        "D005476\tChemical\tfluphenazine\tThe effect of <target> fluphenazine </target> and sulpiride was dose-dependent .",
        "D013469\tChemical\tsulpiride\tThe effect of fluphenazine and <target> sulpiride </target> was dose-dependent .",
        "C534628\tChemical\tSCH 23390\tCombination of <target> SCH 23390 </target> with sulpiride did not induce catalepsy potentiation .",
        "D013469\tChemical\tsulpiride\tCombination of SCH 23390 with <target> sulpiride </target> did not induce catalepsy potentiation .",
        "D002375\tDisease\tcatalepsy\tCombination of SCH 23390 with sulpiride did not induce <target> catalepsy </target> potentiation .",
        "D015647\tChemical\tSKF 38393\tD-1 agonist <target> SKF 38393 </target> or D-2 agonist quinpirole decreased the catalepsy induced by fluphenazine , SCH 23390 or sulpiride .",
        "D019257\tChemical\tquinpirole\tD-1 agonist SKF 38393 or D-2 agonist <target> quinpirole </target> decreased the catalepsy induced by fluphenazine , SCH 23390 or sulpiride .",
        "D002375\tDisease\tcatalepsy\tD-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the <target> catalepsy </target> induced by fluphenazine , SCH 23390 or sulpiride .",
        "D005476\tChemical\tfluphenazine\tD-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the catalepsy induced by <target> fluphenazine </target> , SCH 23390 or sulpiride .",
        "C534628\tChemical\tSCH 23390\tD-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the catalepsy induced by fluphenazine , <target> SCH 23390 </target> or sulpiride .",
        "D013469\tChemical\tsulpiride\tD-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the catalepsy induced by fluphenazine , SCH 23390 or <target> sulpiride </target> .",
        "D015647\tChemical\tSKF 38393\tCombination of <target> SKF 38393 </target> with quinpirole did not cause potentiated inhibitory effect on catalepsy induced by dopamine antagonists .",
        "D019257\tChemical\tquinpirole\tCombination of SKF 38393 with <target> quinpirole </target> did not cause potentiated inhibitory effect on catalepsy induced by dopamine antagonists .",
        "D002375\tDisease\tcatalepsy\tCombination of SKF 38393 with quinpirole did not cause potentiated inhibitory effect on <target> catalepsy </target> induced by dopamine antagonists .",
        "D004298\tChemical\tdopamine\tCombination of SKF 38393 with quinpirole did not cause potentiated inhibitory effect on catalepsy induced by <target> dopamine </target> antagonists .",
        "D002375\tDisease\tcatalepsy\tThe data may indicate that although D-2 receptor blockade is involved in <target> catalepsy </target> , the D-1 receptor may plan a role ."
    ],
    "lines_lemma": [
        "D004298\tChemical\tdopamine\tblockade of both d-1 and d-2 <target> dopamine </target> receptor may induce catalepsy in mouse .",
        "D002375\tDisease\tcatalepsy\tblockade of both d-1 and d-2 dopamine receptor may induce <target> catalepsy </target> in mouse .",
        "D002375\tDisease\tcatalepsy\tthe <target> catalepsy </target> induce by dopamine antagonist have be test and the possible dopamine subtype involve in catalepsy be determine .",
        "D004298\tChemical\tdopamine\tthe catalepsy induce by <target> dopamine </target> antagonist have be test and the possible dopamine subtype involve in catalepsy be determine .",
        "D004298\tChemical\tdopamine\tthe catalepsy induce by dopamine antagonist have be test and the possible <target> dopamine </target> subtype involve in catalepsy be determine .",
        "D002375\tDisease\tcatalepsy\tthe catalepsy induce by dopamine antagonist have be test and the possible dopamine subtype involve in <target> catalepsy </target> be determine .",
        "D004298\tChemical\tDopamine\t<target> Dopamine </target> antagonist fluphenazine , d-1 antagonist sch 23390 or d-2 antagonist sulpiride induce catalepsy .",
        "D005476\tChemical\tfluphenazine\tdopamine antagonist <target> fluphenazine </target> , d-1 antagonist sch 23390 or d-2 antagonist sulpiride induce catalepsy .",
        "C534628\tChemical\tSCH 23390\tdopamine antagonist fluphenazine , d-1 antagonist <target> SCH 23390 </target> or d-2 antagonist sulpiride induce catalepsy .",
        "D013469\tChemical\tsulpiride\tdopamine antagonist fluphenazine , d-1 antagonist sch 23390 or d-2 antagonist <target> sulpiride </target> induced catalepsy .",
        "D002375\tDisease\tcatalepsy\tdopamine antagonist fluphenazine , d-1 antagonist sch 23390 or d-2 antagonist sulpiride induce <target> catalepsy </target> .",
        "D005476\tChemical\tfluphenazine\tthe effect of <target> fluphenazine </target> and sulpiride be dose-dependent .",
        "D013469\tChemical\tsulpiride\tthe effect of fluphenazine and <target> sulpiride </target> be dose-dependent .",
        "C534628\tChemical\tSCH 23390\tcombination of <target> SCH 23390 </target> with sulpiride do not induce catalepsy potentiation .",
        "D013469\tChemical\tsulpiride\tcombination of SCH 23390 with <target> sulpiride </target> do not induce catalepsy potentiation .",
        "D002375\tDisease\tcatalepsy\tcombination of SCH 23390 with sulpiride do not induce <target> catalepsy </target> potentiation .",
        "D015647\tChemical\tSKF 38393\td-1 agonist <target> SKF 38393 </target> or d-2 agonist quinpirole decrease the catalepsy induce by fluphenazine , sch 23390 or sulpiride .",
        "D019257\tChemical\tquinpirole\td-1 agonist SKF 38393 or d-2 agonist <target> quinpirole </target> decrease the catalepsy induce by fluphenazine , sch 23390 or sulpiride .",
        "D002375\tDisease\tcatalepsy\td-1 agonist SKF 38393 or d-2 agonist quinpirole decrease the <target> catalepsy </target> induce by fluphenazine , sch 23390 or sulpiride .",
        "D005476\tChemical\tfluphenazine\td-1 agonist SKF 38393 or d-2 agonist quinpirole decrease the catalepsy induce by <target> fluphenazine </target> , SCH 23390 or sulpiride .",
        "C534628\tChemical\tSCH 23390\td-1 agonist SKF 38393 or d-2 agonist quinpirole decrease the catalepsy induce by fluphenazine , <target> SCH 23390 </target> or sulpiride .",
        "D013469\tChemical\tsulpiride\td-1 agonist SKF 38393 or d-2 agonist quinpirole decrease the catalepsy induce by fluphenazine , sch 23390 or <target> sulpiride </target> .",
        "D015647\tChemical\tSKF 38393\tcombination of <target> SKF 38393 </target> with quinpirole do not cause potentiate inhibitory effect on catalepsy induce by dopamine antagonist .",
        "D019257\tChemical\tquinpirole\tcombination of SKF 38393 with <target> quinpirole </target> do not cause potentiate inhibitory effect on catalepsy induce by dopamine antagonist .",
        "D002375\tDisease\tcatalepsy\tcombination of SKF 38393 with quinpirole do not cause potentiate inhibitory effect on <target> catalepsy </target> induce by dopamine antagonist .",
        "D004298\tChemical\tdopamine\tcombination of SKF 38393 with quinpirole do not cause potentiate inhibitory effect on catalepsy induce by <target> dopamine </target> antagonist .",
        "D002375\tDisease\tcatalepsy\tthe datum may indicate that although d-2 receptor blockade be involve in <target> catalepsy </target> , the d-1 receptor may plan a role ."
    ]
}